Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × cabozantinib × Clear all

NCT01683994 2019-11-08

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Phase 1/2 Completed

49 enrolled 18 charts

Prostatic Neoplasms